Toll Free: 1-888-928-9744
Published: Nov, 2016 | Pages:
100 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)
Global vascular closure devices (VCDs) market is anticipated to reach USD 1.3 billion by 2024, according to a new report by Grand View Research, Inc. Growing popularity of femoral artery cardiac catheterization and high success rate of VCDs for improved patient comfort and shortening of hemostasis time are potential factors for the projected growth of VCDs market over the forecast period. Adoption of VCDs for diagnostic and therapeutic interventions that facilitate endovascular image-guided interventions to detect coronary heart disease are expected to contribute toward the growth of this market throughout the forecast period. Moreover, ability of VCDs to overcome complications, such as prolonged bed rest and patient discomfort caused by manual compression, is expected to revolutionize the market growth over the forecast period. Further Key Findings From the Study Suggest: VCDs offer three types of products, which includes active approximators, passive approximators, and external hemostatic devices. Out of all three, active approximators dominated the market in 2015 as they shorten the time to ambulation and possess high efficiency rate. Amongst the different end-users of VCDs, acute care facilities accounted for the largest share and are expected to maintain their dominant position over the forecast period. This is attributed to the rising popularity of VCDs in acute care treatment facilities. Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the presence of unmet demands by the hospitals and rising R&D investment in this region. Some key players operating in this industry include Cardinal Health; Abbott Laboratories; COOK; Medtronic; W L. Gore & Associates; Boston Scientific Corporation; Biotronik GMBH & CO.KG; TZ Medical, Inc.; C. R. Bard, Inc.; ST. JUDE MEDICAL; Cardiva Medical, Inc.; Merit Medical Systems, Inc.; ESSENTIAL MEDICAL, INC; and Scion BioMedical. This market is expected to witness lucrative growth owing to high level of competitive rivalry, which translates to high revenue generation in this sector. These prominent players are opting for different strategies to boost their status in this market. Companies are involved in developing novel VCDs and in turn broaden their product portfolios. Acquisition and collaboration with small companies in order to enhance presence is also expected to propel growth in this vertical. For instance, in October 2015, Cardinal Health acquired Johnson & Johnson's Cordis business. Cordis is a leader in manufacturing and marketing of cardiology and endovascular devices. This acquisition was intended to expand Cardinal's VCD product catalog to reinforce its status in the market. North America dominated the market in 2015, with over 33% of total revenue. The presence of key players in this region, which are primarily involved in marketing and development of innovative VCDs, to facilitate cardiac surgeries can be attributed to the largest share of North America. Demand of products for monitoring of coronary artery disease is also expected to drive growth.
Table of Contents Chapter 1 Research Methodology 1.1 Information Procurement 1.2 Data Analysis Chapter 2 Executive Summary Chapter 3 Market Snapshot Chapter 4 Market Variables, Trends& Scope 4.1 Market Segmentation& Scope 4.1.1 Market driver analysis 4.1.1.1 Increasing catheterization related procedures 4.1.1.2 Rising preference for minimally-invasive solutions & rise in vascular procedures 4.1.1.3 Technological developments in new vascular closure devices aimed to increase safety among patients 4.1.2 Market restraint analysis 4.1.2.1 High price of products 4.1.2.2 Complications associated with vascular closure devices 4.2 Penetration & Growth Prospect Mapping For End-use, 2015 4.3 Vascular Closure Devices - SWOT Analysis, By Factor (political & legal, economic and technological) 4.4 Industry Analysis - Porter's Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis 5.1 Vascular closure device market: Product Movement Analysis 5.2 Active Approximators 5.2.1 Global active approximators market, 2013 - 2024 (USD Million) 5.2.2 Suture-based devices 5.2.2.1 Global suture-based devices market, 2013 - 2024 (USD Million) 5.2.3 Clip-based devices 5.2.3.1 Global clip-based devices market, 2013 - 2024 (USD Million) 5.3 Passive Approximators 5.3.1 Global passive approximators market, 2013 - 2024 (USD Million) 5.3.2 Collagen plugs 5.3.2.1 Global collagen plugs market, 2013 - 2024 (USD Million) 5.3.3 Sealant- or gel-based devices 5.3.3.1 Global sealant- or gel-based devices market, 2013 - 2024 (USD Million) 5.3.4 Compression-assist devices 5.3.4.1 Global compression-assist devices market, 2013 - 2024 (USD Million) 5.4 External hemostatic devices 5.4.1 Global external hemostatic devices market, 2013 - 2024 (USD Million) Chapter 6 Market Categorization 2: End Use Estimates & Trend Analysis 6.1 Vascular closure device market: End use Movement Analysis 6.2 Acute Care Facilities 6.2.1 Global acute care facilities VCDs market, 2013 - 2024 (USD Million) 6.3 Hospitals 6.3.1 Global hospitals VCDs market, 2013 - 2024 (USD Million) 6.4 Clinics 6.4.1 Global clinics VCDs market, 2013 - 2024 (USD Million) Chapter 7 Market Categorization 3: Regional Estimates & Trend Analysis, by Product, & End-use 7.1 Vascular closure devices Closure Devices Market: Region Movement Analysis 7.2 North America 7.2.1 North America vascular closure device market, 2013 - 2024 (USD Million) 7.2.2 U.S. 7.2.2.1 U.S. vascular closure device market, 2013 - 2024 (USD Million) 7.2.3 Canada 7.2.3.1 Canada vascular closure device market, 2013 - 2024 (USD Million) 7.3 Europe 7.3.1 Europe vascular closure device market, 2013 - 2024 (USD Million) 7.3.2 Germany 7.3.2.1 Germany vascular closure device market, 2013 - 2024 (USD Million) 7.3.3 UK 7.3.3.1 UK vascular closure device market, 2013 - 2024 (USD Million) 7.4 Asia Pacific 7.4.1 Asia Pacific vascular closure device market, 2013 - 2024 (USD Million) 7.4.2 Japan. 7.4.2.1 Japan vascular closure device market, 2013 - 2024 (USD Million) 7.4.3 China 7.4.3.1 China vascular closure device market, 2013 - 2024 (USD Million) 7.5 Latin America 7.5.1 Latin America vascular closure device market, 2013 - 2024 (USD Million) 7.5.2 Brazil 7.5.2.1 Brazil vascular closure device market, 2013 - 2024 (USD Million) 7.5.3 Mexico 7.5.3.1 Mexico vascular closure device market, 2013 - 2024 (USD Million) 7.5.4 Argentina 7.5.4.1 Argentina vascular closure device market, 2013 - 2024 (USD Million) 7.5.5 Venezuela 7.5.5.1 Venezuela vascular closure device market, 2013 - 2024 (USD Million) 7.5.6 Colombia 7.5.6.1 Colombia vascular closure device market, 2013 - 2024 (USD Million) 7.5.7 Chile 7.5.7.1 Chile vascular closure device market, 2013 - 2024 (USD Million) 7.5.8 Peru 7.5.8.1 Peru vascular closure device market, 2013 - 2024 (USD Million) 7.5.9 Ecuador 7.5.9.1 Ecuador vascular closure device market, 2013 - 2024 (USD Million) 7.5.10 Panama 7.5.10.1 Panama vascular closure device market, 2013 - 2024 (USD Million) 7.5.11 Costa Rica 7.5.11.1 Costa Rica vascular closure device market, 2013 - 2024 (USD Million) 7.6 Middle East & Africa 7.6.1 Middle East & Africa vascular closure device market, 2013 - 2024 (USD Million) 7.6.2 South Africa 7.6.2.1 South Africa vascular closure device market, 2013 - 2024 (USD Million) Chapter 8 Competitive Landscape 8.1 Strategy Framework 8.2 Market Participation Categorization 8.3 Company Profiles 8.3.1 Abbott Vascular 8.3.1.1 Company overview 8.3.1.2 Financial performance 8.3.1.3 Product benchmarking 8.3.1.4 Strategic initiatives 8.3.2 Biotronik GMBH & CO.KG 8.3.2.1 Company overview 8.3.2.2 Financial performance 8.3.2.3 Product benchmarking 8.3.2.4 Strategic initiatives 8.3.3 COOK 8.3.3.1 Company overview 8.3.3.2 Financial performance 8.3.3.3 Product benchmarking 8.3.3.4 Strategic initiatives 8.3.4 Medtronic 8.3.4.1 Company overview 8.3.4.2 Financial performance 8.3.4.3 Product benchmarking 8.3.4.4 Strategic initiatives 8.3.5 Boston Scientific Corporation 8.3.5.1 Company overview 8.3.5.2 Financial performance 8.3.5.3 Product benchmarking 8.3.5.4 Strategic initiatives 8.3.6 C. R. Bard, Inc 8.3.6.1 Company overview 8.3.6.2 Financial performance 8.3.6.3 Product benchmarking 8.3.6.4 Strategic initiatives 8.3.7 Cardinal Health 8.3.7.1 Company overview 8.3.7.2 Financial performance 8.3.7.3 Product benchmarking 8.3.7.4 Strategic initiatives 8.3.8 W. L. Gore & Associates 8.3.8.1 Company overview 8.3.8.2 Financial performance 8.3.8.3 Product benchmarking 8.3.8.4 Strategic initiatives 8.3.9 ST. JUDE MEDICAL 8.3.9.1 Company overview 8.3.9.2 Financial performance 8.3.9.3 Product benchmarking 8.3.9.4 Strategic initiatives 8.3.10 TZ Medical, Inc 8.3.10.1 Company overview 8.3.10.2 Financial performance 8.3.10.3 Product benchmarking 8.3.10.4 Strategic initiatives 8.3.11 ScionBioMedical 8.3.11.1 Company overview 8.3.11.2 Financial performance 8.3.11.3 Product benchmarking 8.3.11.4 Strategic initiatives 8.3.12 Merit Medical Systems, Inc 8.3.12.1 Company overview 8.3.12.2 Financial performance 8.3.12.3 Product benchmarking 8.3.12.4 Strategic initiatives 8.3.13 ESSENTIAL MEDICAL, Inc 8.3.13.1 Company overview 8.3.13.2 Financial performance 8.3.13.3 Product benchmarking 8.3.13.4 Strategic initiatives 8.3.14 Cardival Medical, Inc 8.3.14.1 Company overview 8.3.14.2 Financial performance 8.3.14.3 Product benchmarking 8.3.14.4 Strategic initiatives
List of Tables TABLE 1 North America vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 2 North America vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 3 North America active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 4 North America active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 5 North America passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 6 North America passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 7 North America vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 8 North America vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 9 U.S. vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 10 U.S. vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 11 U.S. active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 12 U.S. active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 13 U.S. passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 14 U.S. passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 15 U.S. vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 16 U.S. vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 17 Canada vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 18 Canada vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 19 Canada active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 20 Canada active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 21 Canada passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 22 Canada passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 23 Canada vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 24 Canada vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 25 Europe vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 26 Europe vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 27 Europe active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 28 Europe active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 29 Europe passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 30 Europe passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 31 Europe vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 32 Europe vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 33 Germany vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 34 Germany vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 35 Germany active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 36 Germany active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 37 Germany passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 38 Germany passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 39 Germany vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 40 Germany vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 41 UK vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 42 UK vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 43 UK active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 44 UK active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 45 UK passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 46 UK passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 47 UK vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 48 UK vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 49 Asia Pacific vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 50 Asia Pacific vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 51 Asia Pacific active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 52 Asia Pacific active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 53 Asia Pacific passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 54 Asia Pacific passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 55 Asia Pacific vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 56 Asia Pacific vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 57 Japan vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 58 Japan vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 59 Japan active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 60 Japan active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 61 Japan passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 62 Japan passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 63 Japan vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 64 Japan vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 65 China vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 66 China vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 67 China active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 68 China active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 69 China passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 70 China passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 71 China vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 72 China vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 73 Latin America vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 74 Latin America vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 75 Latin America active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 76 Latin America active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 77 Latin America passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 78 Latin America passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 79 Latin America vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 80 Latin America vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 81 Brazil vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 82 Brazil vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 83 Brazil active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 84 Brazil active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 85 Brazil passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 86 Brazil passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 87 Brazil vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 88 Brazil vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 89 Mexico vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 90 Mexico vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 91 Mexico active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 92 Mexico active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 93 Mexico passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 94 Mexico passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 95 Mexico vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 96 Mexico vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 97 Argentina vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 98 Argentina vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 99 Argentina active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 100 Argentina active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 101 Argentina passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 102 Argentina passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 103 Argentina vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 104 Argentina vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 105 Venezuela vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 106 Venezuela vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 107 Venezuela active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 108 Venezuela active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 109 Venezuela passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 110 Venezuela passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 111 Venezuela vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 112 Venezuela vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 113 Colombia vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 114 Colombia vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 115 Colombia active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 116 Colombia active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 117 Colombia passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 118 Colombia passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 119 Colombia vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 120 Colombia vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 121 Chile vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 122 Chile vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 123 Chile active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 124 Chile active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 125 Chile passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 126 Chile passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 127 Chile vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 128 Chile vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 129 Peru vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 130 Peru vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 131 Peru active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 132 Peru active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 133 Peru passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 134 Peru passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 135 Peru vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 136 Peru vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 137 Ecuador vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 138 Ecuador vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 139 Ecuador active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 140 Ecuador active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 141 Ecuador passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 142 Ecuador passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 143 Ecuador vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 144 Ecuador vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 145 Panama vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 146 Panama vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 147 Panama active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 148 Panama active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 149 Panama passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 150 Panama passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 151 Panama vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 152 Panama vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 153 Costa Rica vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 154 Costa Rica vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 155 Costa Rica active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 156 Costa Rica active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 157 Costa Rica passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 158 Costa Rica passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 159 Costa Rica vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 160 Costa Rica vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 161 MEA vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 162 MEA vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 163 MEA active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 164 MEA active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 165 MEA passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 166 MEA passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 167 MEA vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 168 MEA vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million) TABLE 169 South Africa vascular closure device market estimates, by product, 2013 - 2015 (USD Million) TABLE 170 South Africa vascular closure device market forecasts, by product, 2016 - 2024 (USD Million) TABLE 171 South Africa active approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 172 South Africa active approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 173 South Africa passive approximators market estimates, by product, 2013 - 2015 (USD Million) TABLE 174 South Africa passive approximators market forecasts, by product, 2016 - 2024 (USD Million) TABLE 175 South Africa vascular closure device market estimates, by end-use, 2013 - 2015 (USD Million) TABLE 176 South Africa vascular closure device market forecasts, by end-use, 2016 - 2024 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.